Arias-Arias, J.L.; Vega-Aguilar, F.; Picado-Soto, D.; Corrales-Aguilar, E.; Loría, G.D. In Vitro Inhibition of Zika Virus Replication with Amantadine and Rimantadine Hydrochlorides. Preprints2021, 2021060022. https://doi.org/10.20944/preprints202106.0022.v1
Arias-Arias, J.L., Vega-Aguilar, F., Picado-Soto, D., Corrales-Aguilar, E., & Loría, G.D. (2021). In Vitro Inhibition of Zika Virus Replication with Amantadine and Rimantadine Hydrochlorides. Preprints. https://doi.org/10.20944/preprints202106.0022.v1
Arias-Arias, J.L., Eugenia Corrales-Aguilar and Gilbert D. Loría. 2021 "In Vitro Inhibition of Zika Virus Replication with Amantadine and Rimantadine Hydrochlorides" Preprints. https://doi.org/10.20944/preprints202106.0022.v1
Zika virus (ZIKV) is a mosquito-born flavivirus which human infection became relevant dur-ing recent outbreaks in Latin America, due to its unrecognized association with fetal neurologi-cal disorders. Currently there are no approved effective antivirals or vaccines for treatment or prevention of ZIKV infections. Amantadine and rimantadine are approved antivirals used against susceptible influenza A virus infections, that have been shown to have antiviral activity against other viruses, such as dengue virus (DENV). Here, we report the in vitro effectiveness of both amantadine and rimantadine hydrochlorides against ZIKV replication, resulting in a dose-dependent reduction in viral titers of a ZIKV clinical isolate and two different ZIKV refer-ence strains. Additionally, we demonstrate similar in vitro antiviral activity of these drugs against DENV-1 and yellow fever virus (YFV), although at higher drug concentrations for the later. ZIKV replication was inhibited at drug concentrations well below cytotoxic levels of both compounds, as denoted by the high selectivity indexes obtained with the tested strains. Further work is absolutely needed to determine a potential clinical use of these antivirals against ZIKV infections, but our results suggest the existence of a highly conserved mechanism across fla-vivirus, susceptible to be blocked by modified more specific adamantane compounds.
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.